VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

ADC Therapeutics S.A. (ADCT) Total Return Calculator with Dividends Reinvested

ADC Therapeutics S.A.

Popular:

The total return for ADC Therapeutics S.A. (ADCT) stock is +199.22% over the past 12 months. So far it's up 9.66% this year. The 5-year total return is -82.93%, meaning $10,000 invested in ADCT stock 5 years ago would be worth $1,707 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ADCT 1 year ago, it would be worth $30,394 today — you'd have gained $20,394.

With Dividends Reinvested$30,394+203.94%

Price Only (No DRIP)$30,394+203.94%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ADCT

1Y$29,922+$19,922 (+199.2%)199.2% CAGR

3Y$18,208+$8,208 (+82.1%)22.1% CAGR

5Y$1,707-$8,293 (-82.9%)-29.8% CAGR

10Y$1,302-$8,698 (-87.0%)-18.4% CAGR

15Y$1,302-$8,698 (-87.0%)-12.7% CAGR

20Y$1,302-$8,698 (-87.0%)-9.7% CAGR

30Y$1,302-$8,698 (-87.0%)-6.6% CAGR

ADC Therapeutics S.A. did not pay dividends during this period. Total return = price return.

Loading ADCT total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+9.66%	—	+9.66%	—	$10,966
1Y	+199.22%	199.22%	+199.22%	—	$29,922
3Y	+82.08%	22.11%	+82.08%	—	$18,208
5Y	-82.93%	-29.78%	-82.93%	—	$1,707
10Y	-86.98%	-18.44%	-86.98%	—	$1,302
15Y	-86.98%	-12.71%	-86.98%	—	$1,302
20Y	-86.98%	-9.69%	-86.98%	—	$1,302
30Y	-86.98%	-6.57%	-86.98%	—	$1,302

Risk & Highlights

Best Year+76.50%2025

Worst Year-80.50%2022

Max Drawdown-34.34%2025-10-30 → 2025-12-03 · Recovered 2026-03-10

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+16.48%	+16.48%	—	+0.41%	+16.1pp
2025	+76.50%	+76.50%	—	+16.64%	+59.9pp
2024	+17.75%	+17.75%	—	+24.00%	-6.2pp
2023	-53.76%	-53.76%	—	+24.81%	-78.6pp
2022	-80.50%	-80.50%	—	-19.95%	-60.6pp

ADCT outperformed the S&P 500 by 167.90pp over the past year (+199.22% vs +31.32%).

Loading summary...

ADCT Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ADCTADC Therapeutics S.A.	$491M	+5.2%	+9.7%	+199.2%	—	+82.1%	-82.9%	-87.0%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%
ABBVAbbVie Inc.	$362.6B	-0.8%	-9.1%	+13.1%	+3.6pp	+52.0%	+102.8%	+306.7%
PFEPfizer Inc.	$150.8B	-4.8%	+7.0%	+23.4%	+7.5pp	-18.4%	-11.3%	+30.7%
AIXIXiao-I Corporation	$8M	-7.1%	+73.7%	-77.3%	—	-98.6%	-98.6%	-98.6%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
ALNYAlnylam Pharmaceuticals, Inc.	$40.4B	-8.3%	-24.3%	+12.3%	—	+44.3%	+129.4%	+445.5%
BCYCBicycle Therapeutics plc	$357M	+5.3%	-22.9%	-30.4%	—	-76.2%	-83.8%	-57.1%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
ARVNArvinas, Inc.	$656M	-8.6%	-10.5%	+47.6%	—	-58.4%	-83.8%	-36.1%

Compare:ADCT vs RCUS ADCT vs MGNX ADCT vs ABBV ADCT vs RCUS vs MGNX

About ADCT Dividend Returns

ADC Therapeutics S.A. (ADCT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ADCT over the past year?

ADC Therapeutics S.A. (ADCT) delivered a return of 199.22% over the past year. Since ADCT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ADCT be worth today?

A $10,000 investment in ADC Therapeutics S.A. one year ago would be worth $29,922 today, representing a gain of $19,922.

Q3Does ADCT pay dividends?

ADC Therapeutics S.A. (ADCT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ADCT, the total return equals the price-only return.

Q4Did ADCT beat the S&P 500?

Yes, ADC Therapeutics S.A. (ADCT) outperformed the S&P 500 by 167.90 percentage points over the past year. ADCT delivered a total return of 199.22%, compared to the S&P 500's 31.32%. This 167.90pp alpha means investors in ADCT earned more than a passive S&P 500 index fund.

Q5What is ADCT's worst drawdown?

ADC Therapeutics S.A. (ADCT) experienced a maximum drawdown of -34.34% over the past year, declining from its peak on 2025-10-30 to its trough on 2025-12-03. The stock recovered to its prior peak by 2026-03-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ADCT's long-term total return over 10, 20, or 30 years?

Here are ADC Therapeutics S.A. (ADCT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -87.0% (-18.4% CAGR) — $10,000 would have grown to $1,302. Over 20 years: -87.0% total return (-9.7% CAGR) — $10,000 → $1,302. Over 30 years: -87.0% total return (-6.6% CAGR) — $10,000 → $1,302. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ADCT's best and worst year?

ADC Therapeutics S.A.'s best calendar year was 2025 with a total return of 76.5%. Its worst year was 2022 with a total return of -80.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 157.0 percentage points.